support thyroid research
Clinical Thyroidology for Patients

Clinical Thyroidology for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association.
Editor-in-chief, Alan Farwell, MD

Volume 7 Issue 2

Now available in pdf format for saving and printing and Web page format for viewing online

PDF Format for Saving and Printing
Clinical Thyroidology for the Public Volume 7 Issue 2 (PDF file, 555 KB)


Editor’s Comments

THYROID AND PREGNANCY How much levothyroxine should be started for hypothyroidism diagnosed during pregnancy?
Abalovich M et al Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy. Thyroid 2013;23:1479-83. Epub September 20, 2013.
(PDF File for saving and printing, 74 KB)

HYPERTHYROIDISM Some patients with apparent Graves’ disease do not have an autoimmune thyroid disorder
Nishihara E et al, The prevalence of TSH receptor germline mutations and clinical courses in 89 hyperthyroid patients with diffuse goiter and negative anti-TSH receptor antibodies. Thyroid. November 26, 2013 [Epub ahead of print].
(PDF File for saving and printing, 77KB)

HYPERTHYROIDISM A 10-year analysis of thyrotoxic periodic paralysis
Chang C-C et al 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol 2013;169:529-36.
(PDF File for saving and printing, 69 KB)

THYROID CANCER When thyroglobulin is undetectable, is any further testing needed in following patients with thyroid cancer?
Giovanella L et al, Unstimulated high-sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: a meta-analysis. J Clin Endocrinol Metab. 2013 Nov 27.10.1001/jamainternmed.2013.9245.
(PDF File for saving and printing, 119 KB)

THYROID CANCER Analysis of microRNAs in papillary thyroid cancer
Dettmer M et al. Comprehensive microRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid 2013 Nov;23(11):1383-9.
(PDF File for saving and printing, 74 KB)

THYROID CANCER Mutations of the RAS oncogene are found in follicular variant papillary thyroid carcinoma
Gupta N et al. RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers. J Clin Endocrinol Metab 2013;98:E914-22. Epub March 28, 2013; doi: 10.1210/jc.2012-3396.
(PDF File for saving and printing, 74 KB)


Sixth International Thyroid awareness Week May 25-31, 2014